Literature DB >> 10215930

Amyloid precursor protein of Alzheimer's disease: evidence for a stable, full-length, trans-membrane pool in primary neuronal cultures.

E Storey1, M Katz, Y Brickman, K Beyreuther, C L Masters.   

Abstract

We and colleagues have shown that the amyloid protein precursor of Alzheimer's disease (APP) is distributed along the surface of neurites of fixed but nonpermeabilized neurons in primary culture in a segmental pattern, which shows colocalization with some markers of adhesion patches. This is in contrast to the diffuse pattern of immunoreactivity seen after permeabilization. We have also recently demonstrated that the APP in these surface patches is likely to be integral to the membrane rather than secreted and re-adsorbed, based on alkali stripping experiments and on soluble APP adsorption experiments. Total cellular APP has previously been shown to have a short half-life of approximately 30-60 min. We confirm this in neurons in primary culture in pulse-chase experiments using short labelling times. Additionally, we provide evidence that a separate, stable pool of neuronal APP can be demonstrated in pulse-chase experiments using long labelling times. Experiments involving inhibition of protein synthesis suggest that this corresponds with the surface, segmental pool. Metabolic labelling followed by surface biotinylation and two-stage precipitation demonstrates that the surface APP is trans-membrane and full-length (not carboxyl-terminal truncated), and confirms that the surface APP belongs to the stable pool. This two-stage procedure is necessary as the surface APP appears to be present in low copy number, and is difficult to detect by direct labelling. This information is consistent with a role for APP in stable cell-matrix or cell-cell interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215930     DOI: 10.1046/j.1460-9568.1999.00599.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons.

Authors:  C Kaether; P Skehel; C G Dotti
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

2.  Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

Authors:  Anthony R White; Gerd Multhaup; Denise Galatis; William J McKinstry; Michael W Parker; Rüdiger Pipkorn; Konrad Beyreuther; Colin L Masters; Roberto Cappai
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

3.  Large quantities of Abeta peptide are constitutively released during amyloid precursor protein metabolism in vivo and in vitro.

Authors:  Abhay Moghekar; Sneha Rao; Ming Li; Dawn Ruben; Andrew Mammen; Xiaopei Tang; Richard J O'Brien
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

4.  The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.

Authors:  Tobias Brummer; Martina Pigoni; Armando Rossello; Huanhuan Wang; Peter J Noy; Michael G Tomlinson; Carl P Blobel; Stefan F Lichtenthaler
Journal:  FASEB J       Date:  2018-02-07       Impact factor: 5.191

5.  Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins.

Authors:  Yuzuru Taguchi; Zhen-Dan Shi; Brian Ruddy; David W Dorward; Lois Greene; Gerald S Baron
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

6.  Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers.

Authors:  Matthias Gralle; Michelle Gralle Botelho; Fred S Wouters
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

7.  Quetiapine attenuates glial activation and proinflammatory cytokines in APP/PS1 transgenic mice via inhibition of nuclear factor-κB pathway.

Authors:  Shenghua Zhu; Ruoyang Shi; Victor Li; Junhui Wang; Ruiguo Zhang; Adrien Tempier; Jue He; Jiming Kong; Jun-Feng Wang; Xin-Min Li
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.